跳至主要内容
临床试验/NCT02896049
NCT02896049撤回不适用

Celsius TCS Hyperthermia System Post Market Clinical Follow-Up (PMCF) Trial - Vigilance Registry

Celsius42 GmbH0 个研究点开始时间: 2016年11月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
主要终点
failures of the device as well as failure of persons using the device during treatment

研究概览

简要总结

Based on the basic data of all patients foreseen for a local hyperthermia in the participating centers the failure rate (of the Celsius TCS Hyperthermia System) and the complication rate (injury to the patients) will be recorded.

详细描述

During this PMCF Trial from each participating center the internal data of all Celsius TCS Hyperthermia devices are collected. The participating centers are obligated to report any device-related failure and Adverse Event (injury to the patient). The center reports together with the device-internal data allows to calculate the failure and the complication rates. It will be analyzed regarding the kind of tumor and the concomitant treatment (radiotherapy and/or chemotherapy). The outcome groups (with/without failure or complication) will be analyzed regarding demographic and treatment parameters.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • treatment performed with the Celsius TCS Hyperthermia System

排除标准

  • not applicable -

结局指标

主要结局

failures of the device as well as failure of persons using the device during treatment

时间窗: one month after treatment

Based on the risk analysis the failures occurring during treatment will be classified and their frequency will be evaluated. This will be done using the investigators' judgment regarding severity of the failures (as minor, moderate, severe).

any injury, harm or medically relevant discomfort occurring for the patients or the staff

时间窗: one month after treatment

Based on the risk analysis the injuries occurring during treatment will be classified and their frequency will be evaluated. This will be done using the investigators' judgment regarding severity of the failures (as minor, moderate, severe).

次要结局

未报告次要终点

研究者

发起方
Celsius42 GmbH
申办方类型
Industry
责任方
Sponsor

相似试验